Stem Cell Authority, Ltd. (SCAL)
Stem Cell Authority, Ltd. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Fairlawn, OH, CN. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $17,424. On trailing twelve-month figures it carries a trailing P/E of -45.87, a net margin of 0.0%. Its beta of 3.01 implies it has historically moved more than the broad market.
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly found within a newborn's umbilical cord. SCAL provides healthcare professionals involved in childbirth throughout the United States with advanced technology to offer these vital stem cell preservation services to their maternity patients. The company's operations are based in Fairlawn, Ohio.
Stem Cell Authority, Ltd. is most often compared with the following Healthcare names: